Molecular Therapy Advances
Издатель: Elsevier · ISSN 3117-387X · 80 статей
- Assessing Germline Transmission Risk and First-in-Human Dose Selection for In Vivo Gene Therapies
- A dual-function adenoviral system for transgene delivery and gene editing for host factor studies in a murine model of SARS-CoV-2 infection
- A Novel Human iPSC-derived Liver Model for In Vitro Assessment of AAV Gene Therapies
- Cryo-EM Mapping of Human Neutralizing Antibodies Reveals 3-fold Antigenic “Hotspot” on the AAV2 Capsid
- Validation of an agonistic canine anti-CD3ε antibody for the production of metabolically fit T cells for adoptive therapy
- A Streamlined AAV Purification Process via Engineered Affinity Tag-Assisted Liquid-Liquid Phase Separation
- Neutralizing antibodies against 20 different AAV variants are rare in human cerebrospinal fluid despite high seroprevalences.
- A Parametric Study of AAV-PHP.eB for CNS Gene Transfer in C57BL/6J Mice: Transduction Kinetics, Safety Profiles, and Applications
- From GMP manufacture of CellThRPE1 to regulatory authorisation of a First-in-Human Phase I clinical trial in geographic atrophy
- Automated Ex Vivo Processing Enables Lentiviral Transduction and Preserves Stemness in Human CD34+ Hematopoietic Stem and Progenitor Cells
- Postnatal gene restoration in succinic semialdehyde dehydrogenase deficiency (SSADHD) reveals phenotype reversibility
- AAV9-PMM2 therapy rescues neuronal phenotypes in a human cortical organoid model of PMM2-CDG
- The antileukemic efficacy of CAR-NK cells is shaped by clonal expression of inhibitory KIRs and patient-encoded KIR ligands
- Decoupling Efficacy from Toxicity: Engineering Spatial Control in AAV-Mediated Gene Therapy
- Clinical immunogenicity in rAAV gene therapy: Insights and implications
- Stealthy lentiviral vectors: Breaking the barriers to systemic in vivo gene delivery
- AAV serotype IVDs for patient selection in gene therapy development: Technical and regulatory considerations by ARDAT consortium
- SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential
- Baculovirus helper functions during recombinant adeno-associated virus production in insect cells for gene therapy applications
- Management of acute infusion-related reactions in AAV gene therapy guided by mechanistic insight
- Sequence-based artificial intelligence-guided inhibitory peptides to counteract AAV neutralizing antibodies in gene therapy
- Base editing rescues a hereditary motor neuron disease in mouse and patient-derived iPSC organoid models
- Automated zonal-rotor CsCl ultracentrifugation with ÄKTA-based fractionation removes empty and intermediate AAV capsids
- Digenome-Detect: Accurate, statistics-based analysis software for identifying off-target cleavage sites in genome editing
- Transduction efficiency in clinical CAR T cell products: A retrospective study at a single center
- pSIM: A next generation in vitro mRNA potency assay
- Calcineurin-mediated regulation of macrophage plasticity drives anti-tumor activity
- Integrating multiplex digital PCR and long-read sequencing toward standardized genome integrity and purity characterization of rAAV9
- DNA ejection and AAV capsid degradation under thermal stress: Insights from CDMS and native digestion strategies
- Development and qualification of quantitative assays for detecting process-related nucleic acid impurities in recombinant AAV preparations